Do you want to read an article? Please log in or register.
Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations
Ocular Oncology
Related content
Ocular Oncology
Estimation of the timing of BAP1 mutation in uveal melanoma progression
Sci Rep
Uner OE, See TRO, Szalai E, Grossniklaus HE, Stålhammar G
doi: 10.1038/s41598-021-88390-6
RECOMMENDED
Ocular Oncology
Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival
★ 2
Recommended by
Prof. Dr Daniel Barthelmes, Faculty Member
doi: 10.1001/jamaophthalmol.2019.5403.
Ocular Oncology
BCC developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS
Genes Chromosomes Cancer.
Melzer C, Sharma A, Peters S, Aretz S, Biswas A, Holz FG, Loeffler KU, Herwig-Carl MC
doi: 10.1002/gcc.22724.
Ocular Oncology
Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D
Ophthalmology.
Vichitvejpaisal P, Dalvin LA, Mazloumi M, Ewens KG, Ganguly A, Shields CL
doi: 10.1016/j.ophtha.2019.04.027.
Ocular Oncology
Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma
Am J Ophthalmol.
Cai L, Paez-Escamilla M, Walter SD, Tarlan B, Decatur CL, Perez BM, Harbour JW
doi: 10.1016/j.ajo.2018.07.045.
Ocular Oncology
Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients
Invest Ophthalmol Vis Sci.
Drabarek W, Yavuzyigitoglu S, Obulkasim A, van Riet J, Smit KN, van Poppelen NM, Vaarwater J, Brands T, Eussen B, Verdijk RM, Naus NC, Mensink HW, Paridaens D, Boersma E, van de Werken HJG, Kilic E, de Klein A, for the Rotterdam Ocular Melanoma Study Group.
doi: 10.1167/iovs.18-24818.
Ocular Oncology
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
Nat Commun.
Johansson PA, Brooks K, Newell F, Palmer JM, Wilmott JS, Pritchard AL, Broit N, Wood S, Carlino MS, Leonard C, Koufariotis LT, Nathan V, Beasley AB, Howlie M, Dawson R, Rizos H, Schmidt CW, Long GV, Hamilton H, Kiilgaard JF, Isaacs T, Gray ES, Rolfe OJ, Park JJ, Stark A, Mann GJ, Scolyer RA, Pearson JV, van Baren N, Waddell N, Wadt KW, McGrath LA, Warrier SK, Glasson W, Hayward NK
doi: 10.1038/s41467-020-16276-8.
Ocular Oncology
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition
Eur J Cancer.
Heppt MV, Heinzerling L, Kähler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, Meier F, Terheyden P, Schell B, Herbst R, Göppner D, Kiecker F, Rafei-Shamsabadi D, Haferkamp S, Huber MA, Utikal J, Ziemer M, Bumeder I, Pfeiffer C, Schäd SG, Schmid-Tannwald C, Tietze JK, Eigentler TK, Berking C
doi: 10.1016/j.ejca.2017.05.038.
Ocular Oncology
Genetic prognostication in uveal melanoma
Acta Ophthalmol.
Dogrusöz M, Jager MJ
doi: 10.1111/aos.13580.